Genmab A (GMAB) EBT Margin (2018 - 2026)
Genmab A (GMAB) posted EBT Margin of 8.26% for Q1 2026, down 80.87% on a QoQ basis from 43.16% in Q3 2025, and down 2587.0% year-over-year from 0.33% in Q1 2025.
Genmab A (GMAB) EBT Margin (2018 - 2026) Analysis & Trends
Genmab A's EBT Margin history runs 5 years deep, the most recent figure standing at 8.26% for Q1 2026.
- Quarterly EBT Margin fell 2587.0% year-over-year to 8.26% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36.09% (down 2383.0% YoY) and the FY2025 annual result came in at 32.37%, up 324.0% from the prior year.
- EBT Margin was 8.26% for Q1 2026 at Genmab A, down from 43.16% in the prior quarter.
- Across five years, EBT Margin topped out at 43.16% in Q3 2025 and bottomed at 8.26% in Q1 2026.
- A 3-year average of 34.94% and a median of 40.23% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2025 — EBT Margin soared 636 bps — and 2026, when it sank 2587 bps.
- Genmab A's EBT Margin stood at 36.81% in 2024, then increased by 17 bps to 43.16% in 2025, then sank by 81 bps to 8.26% in 2026.
- Business Quant data shows GMAB's EBT Margin at 8.26% in Q1 2026, 43.16% in Q3 2025, and 40.67% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | 8.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.26% |
| Sep 30, 2025 | 43.16% |
| Jun 30, 2025 | 40.67% |
| Mar 31, 2025 | 34.13% |
| Sep 30, 2024 | 36.81% |
| Jun 30, 2024 | 40.23% |
| Mar 31, 2024 | 41.29% |
| Dec 31, 2019 | 67.21% |
| Sep 30, 2019 | 67,248,452,652,513.27% |
| Dec 31, 2018 | 38.52% |